US Patent 8686025 Therapeutic lactams

Patent 8686025 was granted and assigned to Allergan, Inc. on April, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Allergan, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

86860250

Patent Inventor Names

David W. Old0

Robert M. Burk0

Date of Patent

April 1, 2014

Patent Application Number

123347040

Date Filed

December 15, 2008

Patent Citations Received

‌

US Patent 11919839 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

Patent Primary Examiner

‌

Samantha Shterengarts

Patent abstract

Disclosed herein is a compound having a structure

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8686025 Therapeutic lactams

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API